Lanean...
The forkhead box M1 transcription factor as a candidate of target for anti‐cancer immunotherapy
The present study attempted to identify a target antigen for immunotherapy for cholangiocarcinoma. Forkhead box M1 (FOXM1) was selected as a candidate antigen based on the data of previous cDNA microarray analysis of clinical samples of cholangiocarcinoma. The level of FOXM1 mRNA was more than 4 tim...
Gorde:
| Argitaratua izan da: | Int J Cancer |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Wiley Subscription Services, Inc., A Wiley Company
2009
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7165995/ https://ncbi.nlm.nih.gov/pubmed/19688828 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.24836 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|